**Core Concept:** Leprosy is a chronic infectious disease caused by Mycobacterium leprae and M. leprae, which primarily affects the skin, peripheral nerves, and mucous membranes. Multibacillary leprosy is a more severe form of the disease characterized by the presence of numerous bacilli in the body, requiring a more intensive treatment regimen as compared to paucibacillary leprosy.

**Why the Correct Answer is Right:** The duration of treatment for multibacillary leprosy is 6 months, which is twice as long as the treatment for paucibacillary leprosy (3 months). This extended duration ensures that the high bacillary load in multibacillary leprosy can be reduced to a level that is easier to treat and prevent the spread of the infection.

**Why Each Wrong Option is Incorrect:**

A. **Option A**: Treatment durations shorter than 6 months are not effective in reducing the bacillary load significantly, increasing the risk of incomplete treatment and relapse.

B. **Option B**: Treatment durations longer than 6 months may lead to drug toxicity and the development of drug-resistant strains, compromising treatment outcomes.

C. **Option C**: The duration of treatment for paucibacillary leprosy is typically 3 months, not the other way around. Multibacillary leprosy requires a longer treatment duration.

D. **Option D**: The treatment regimen for multibacillary leprosy involves a combination of drugs, not just a single drug. The correct answer (6 months) is the combined therapy duration, ensuring adequate coverage of the infection.

**Clinical Pearl:** Multibacillary leprosy treatment should be individualized based on the type of leprosy and the response to treatment. A multidrug therapy (MDT) consisting of dapsone, rifampicin, and either of the following drugs: clofazimine, ofloxacin, or para-aminosalicylic acid, is used. Monitoring patient response and adjusting the treatment duration accordingly is crucial to ensure effective and safe treatment.

**Correct Answer:** Multibacillary leprosy treatment typically consists of a combination of drugs for six months, ensuring the reduction of bacillary load and preventing the development of drug-resistant strains.